JT
ENTA icon

Jupiter Topco’s Enanta Pharmaceuticals ENTA Stock Holding History

Jupiter Topco’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$53.3M Buy
+3,654,920
New +$49.1M 0.02% 428

Other funds holding ENTA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jupiter Topco's ENTA Position: Q2 2026 in Review

Jupiter Topco opened a new position in Enanta Pharmaceuticals (ENTA) in Q2 2026: 3,654,920 shares worth $53.3M. The stake represents 0.02% of the portfolio and ranks #428 among its holdings.

116 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Jupiter Topco held 3,654,920 shares of Enanta Pharmaceuticals worth $53.3M as of Q2 2026.
  • Enanta Pharmaceuticals was a new Jupiter Topco position in Q2 2026.
  • Enanta Pharmaceuticals made up 0.02% of Jupiter Topco's portfolio in Q2 2026, its #428 holding.
  • 116 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Jupiter Topco's 13F filing for Q2 2026, filed 14 Aug 2026.